CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · IEX Real-Time Price · USD
1.055
+0.005 (0.48%)
Jul 22, 2024, 10:02 AM EDT - Market open
CNS Pharmaceuticals Employees
As of December 31, 2023, CNS Pharmaceuticals had 5 total employees, including 3 full-time and 2 part-time employees. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,492,805
Market Cap
3.08M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5 | 0 | - |
Dec 31, 2022 | 5 | 0 | - |
Dec 31, 2021 | 5 | 0 | - |
Dec 31, 2020 | 5 | 0 | - |
Dec 31, 2019 | 5 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Aditxt | 47 |
TC Biopharm (Holdings) | 41 |
Healthcare Triangle | 31 |
INVO Bioscience | 30 |
Petros Pharmaceuticals | 21 |
Virax Biolabs Group | 11 |
ZyVersa Therapeutics | 7 |
Alzamend Neuro | 7 |
CNSP News
- 6 days ago - CNS Pharmaceuticals to Participate in the Virtual Investor Closing Bell Series - Accesswire
- 18 days ago - CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement - Accesswire
- 7 weeks ago - CNS Pharmaceuticals Announces Reverse Stock Split - Accesswire
- 2 months ago - CNS Pharmaceuticals to Present at Alliance Global Partner's 2024 Healthcare Company Showcase - Accesswire
- 2 months ago - CNS Pharmaceuticals Reports First Quarter 2024 Financial Results - Accesswire
- 3 months ago - CNS Pharmaceuticals to Present at the LSX World Congress 2024 - Accesswire
- 3 months ago - CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity - Accesswire
- 3 months ago - CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements - Accesswire